During the past decade, Auerbach Hematology and Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auerbach Hematology and Oncology" #1 collaborator was "AMAG Pharmaceuticals, Inc." with 3 trials as a collaborator, "MedStar Women's Care at Honeygo" with 1 trials as a collaborator and "Pharmacosmos A/S" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Auerbach Hematology and Oncology" are "Iron Deficiency Anemia" (3 trials), "Pregnancy" (2 trials), "Iron Deficiency (Without Anemia)" (1 trials), "Multiple Myeloma" (1 trials) and "Non Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Auerbach Hematology and Oncology" in a lesser frequency.

Most popular intervention types in "Auerbach Hematology and Oncology" are "Drug" (6 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (1 trials), "Dexamethasone" (1 trials), "Ferrous sulfate" (1 trials), "Ferrous sulfate tablets" (1 trials) and "Ferumoxytol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Auerbach Hematology and Oncology" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Auerbach Hematology and Oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Auerbach Hematology and Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Auerbach Hematology and Oncology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".